Highlights from: The 29th Annual San Antonio Breast Cancer Symposium; San Antonio, TX; December 2006 - Bevacizumab combination regimens as first-line therapy of metastatic breast cancer: The NCCTG N0432 and XCALiBr trials

Jennifer Klem, Zachary Moore, Susan Peck, Debu Tripathy, Joyce O'Shaughnessy

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Highlights from: The 29th Annual San Antonio Breast Cancer Symposium; San Antonio, TX; December 2006 - Bevacizumab combination regimens as first-line therapy of metastatic breast cancer: The NCCTG N0432 and XCALiBr trials'. Together they form a unique fingerprint.